Suicidal behavior and depression in smoking cessation treatments.
BACKGROUND: Two treatments for smoking cessation--varenicline and bupropion--carry Boxed Warnings from the U.S. Food and Drug Administration (FDA) about suicidal/self-injurious behavior and depression. However, some epidemiological studies report an increased risk in smoking or smoking cessation ind...
Main Authors: | Thomas J Moore, Curt D Furberg, Joseph Glenmullen, John T Maltsberger, Sonal Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3206890?pdf=render |
Similar Items
-
Prescription drugs associated with reports of violence towards others.
by: Thomas J Moore, et al.
Published: (2010-01-01) -
Are Smoking Cessation Treatments Associated with Suicidality Risk? An Overview
by: J. Kim Penberthy, et al.
Published: (2016-01-01) -
Are Smoking Cessation Treatments Associated with Suicidality Risk? An Overview
by: J. Kim Penberthy, et al.
Published: (2016-04-01) -
Smoking and depression: is smoking cessation effective?
by: Eleni Ischaki, et al.
Published: (2009-02-01) -
Gender differences and smoking cessation in the Japanese
smoking cessation treatment program
by: Meng Li, et al.
Published: (2020-11-01)